Brain Health Supplements Market Size, Share | Report 2023-2032
The global brain health supplements market was valued at USD 9.17 billion in 2022 and it is predicted to surpass around USD 26.25 billion by 2032 with a CAGR of 11.09% from 2023 to 2032.
Key Pointers
Report Scope of the Brain Health Supplements Market
| Report Coverage | Details |
| Market Size in 2022 | USD 9.17 billion |
| Revenue Forecast by 2032 | USD 26.25 billion |
| Growth rate from 2023 to 2032 | CAGR of 11.09% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Natural Factors Nutritional Products Ltd; Onnit Labs, Inc.; Purelife Bioscience Co., Ltd; Intelligent Labs; Accelerated Intelligence Inc.; NOW Foods; HVMN Inc.; Teva Pharmaceutical Industries Ltd.; Peak Nootropics; Alternascript |
The growth is attributed to rising awareness regarding mental health issues, such as lack of attention and focus, declining memory, anxiety, and depression. Moreover, the increasing adoption of natural and herbal health products is anticipated to fuel the industry’s growth over the forecast period. Rising demand for multi-efficacy drugs that work as energy boosters, antidepressants, brain enhancers, and resist anxiety is expected to drive greater R&D activities in this industry. Moreover, increasing demand by the sports industry to improve the brain efficacy of players is also expected to generate growth opportunities for the global market.
People associated with academic and professional arenas are expected to contribute to the demand for the brain health supplements industry over the next few years. In addition, these products are likely to gain high acceptance among people suffering from various brain ailments such as depression, dementia, anxiety, and insomnia to name a few.
According to an article published by the World Health Organization (WHO), in September 2021, approximately 280 million people of all ages suffered from depression globally. In the U.S., anxiety disorder is one of the most common mental illnesses among people.
As per an article published by the Anxiety & Depression Association of America in October 2022, approximately 19.1% of the adult population, i.e. 40 million people, in the U.S. suffered from anxiety. Increasing awareness about mental illnesses is expected to widen the scope of application for brain health supplements in near future.
Moreover, these products are employed for the treatment of other cognitive and age-related disorders including hyperactivity as well as Parkinson's disease. Growing concern concerning mental health wellness and cognitive development is expected to augment the growth of the brain health supplements market.
Brain health supplements for memory enhancement registered the highest market penetration in 2022. Growing competition in academic and professional fields has been driving the growth of these products. Moreover, the increasing need for memory improvement among the older population was also one of the driving factors for such supplements.
In addition, the cost-effectiveness, as well as easy accessibility to these products, is expected to boost product adoption among consumers. Such factors are likely to contribute to segment growth.
For the last few years, supplements for the enhancement of cognitive function have mostly focused on aging baby boomers to help slow down or prevent cognitive disorders. With the development and awareness about these products, they are now being more closely targeted at millennials, as this demographic is under constant pressure to increase its productivity.
Brain Health Supplements Market Segmentations:
By Product
By Application
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Brain Health Supplements Market
5.1. COVID-19 Landscape: Brain Health Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Brain Health Supplements Market, By Product
8.1. Brain Health Supplements Market, by Product, 2023-2032
8.1.1. Natural Molecules
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Herbal Extract
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Vitamins & Minerals
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Brain Health Supplements Market, By Application
9.1. Brain Health Supplements Market, by Application, 2023-2032
9.1.1. Memory Enhancement
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Attention & Focus
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Depression & Mood
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Sleep & Recovery
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Anti-aging & Longevity
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Stress & Anxiety
9.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Brain Health Supplements Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2020-2032)
10.1.2. Market Revenue and Forecast, by Application (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.1.3.2. Market Revenue and Forecast, by Application (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.2. Market Revenue and Forecast, by Application (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.3.2. Market Revenue and Forecast, by Application (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.2. Market Revenue and Forecast, by Application (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.3.2. Market Revenue and Forecast, by Application (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.3.2. Market Revenue and Forecast, by Application (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.5.3.2. Market Revenue and Forecast, by Application (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
Chapter 11. Company Profiles
11.1. Natural Factors Nutritional Products Ltd
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Onnit Labs, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Purelife Bioscience Co., Ltd
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Intelligent Labs
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Accelerated Intelligence Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. NOW Foods
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. HVMN Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Teva Pharmaceutical Industries Ltd.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Peak Nootropics
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Alternascript
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers